Aware Super Pty Ltd as trustee of Aware Super grew its position in Colgate-Palmolive Company (NYSE:CL - Free Report) by 251.5% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 129,433 shares of the company's stock after acquiring an additional 92,613 shares during the period. Aware Super Pty Ltd as trustee of Aware Super's holdings in Colgate-Palmolive were worth $11,765,000 at the end of the most recent quarter.
A number of other institutional investors have also recently modified their holdings of the business. Cornerstone Wealth Management LLC grew its position in shares of Colgate-Palmolive by 1.2% during the first quarter. Cornerstone Wealth Management LLC now owns 9,035 shares of the company's stock worth $847,000 after buying an additional 110 shares in the last quarter. Grimes & Company Inc. raised its stake in Colgate-Palmolive by 1.0% during the 2nd quarter. Grimes & Company Inc. now owns 12,495 shares of the company's stock worth $1,136,000 after acquiring an additional 118 shares in the last quarter. RFG Advisory LLC grew its stake in Colgate-Palmolive by 1.4% during the 2nd quarter. RFG Advisory LLC now owns 9,227 shares of the company's stock worth $839,000 after buying an additional 123 shares during the last quarter. Redhawk Wealth Advisors Inc. increased its holdings in shares of Colgate-Palmolive by 2.4% in the 2nd quarter. Redhawk Wealth Advisors Inc. now owns 5,467 shares of the company's stock valued at $497,000 after acquiring an additional 129 shares during the period. Finally, MONECO Advisors LLC raised its holdings in shares of Colgate-Palmolive by 2.2% in the first quarter. MONECO Advisors LLC now owns 6,051 shares of the company's stock valued at $567,000 after buying an additional 133 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several equities research analysts recently weighed in on the company. Wells Fargo & Company decreased their price target on Colgate-Palmolive from $83.00 to $80.00 and set an "underweight" rating for the company in a report on Thursday, September 25th. Morgan Stanley decreased their target price on shares of Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. Bank of America cut their price target on shares of Colgate-Palmolive from $98.00 to $88.00 and set a "buy" rating for the company in a report on Wednesday, October 8th. Weiss Ratings reiterated a "hold (c)" rating on shares of Colgate-Palmolive in a research note on Wednesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft set a $86.00 target price on shares of Colgate-Palmolive in a research report on Friday, October 10th. Eight research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $92.21.
Get Our Latest Research Report on CL
Colgate-Palmolive Trading Down 0.9%
NYSE:CL opened at $77.67 on Thursday. Colgate-Palmolive Company has a 52-week low of $76.68 and a 52-week high of $101.89. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79. The stock has a fifty day simple moving average of $82.20 and a 200-day simple moving average of $87.60. The company has a market capitalization of $62.77 billion, a PE ratio of 21.82, a price-to-earnings-growth ratio of 4.60 and a beta of 0.34.
Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm had revenue of $5.11 billion during the quarter, compared to the consensus estimate of $5.03 billion. During the same period last year, the firm posted $0.91 EPS. The firm's revenue for the quarter was up 1.0% on a year-over-year basis. On average, equities research analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.
Colgate-Palmolive Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be paid a $0.52 dividend. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a yield of 2.7%. Colgate-Palmolive's dividend payout ratio is presently 58.43%.
Colgate-Palmolive Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.